WMSA
ELGX

Weiss Multi-Strategy Advisers’s Endologix Inc ELGX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,000
Closed -$515K – 1030
2014
Q1 		$515K Buy
+4,000
New +$622K 0.01% 649

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ELGX Position: Q3 2018 in Review

Weiss Multi-Strategy Advisers sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 2,114 shares — an estimated $120K sold.

Weiss Multi-Strategy Advisers first reported a position in ELGX in Q2 2013 and held it in 15 quarters. The position peaked at $2.9M in Q3 2013. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • Weiss Multi-Strategy Advisers reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 2,114 Endologix Inc shares in Q3 2018, an estimated $120K.
  • Weiss Multi-Strategy Advisers first reported a position in Endologix Inc in Q2 2013 and held it in 15 quarters.
  • Weiss Multi-Strategy Advisers's Endologix Inc position peaked at $2.9M in Q3 2013.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.